Genmab A/s Earnings

Genmab A/s’s revenue jumped 4.38% since last year same period to $6722.82Mn in the Q4 2025. On a quarterly growth basis, Genmab A/s has generated 557.81% jump in its revenue since last 3-months.

Genmab A/s’s net profit fell -94.88% since last year same period to $196.98Mn in the Q4 2025. On a quarterly growth basis, Genmab A/s has generated -50.88% fall in its net profits since last 3-months.

Genmab A/s’s net profit margin fell -95.09% since last year same period to 2.93% in the Q4 2025. On a quarterly growth basis, Genmab A/s has generated -92.53% fall in its net profit margins since last 3-months.

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.14 - a -62.16% fall from last quarter’s estimates.

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.14.

Genmab A/s’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Genmab A/s has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.